USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NANORELEASE TECHNOLOGIES, LLC
Address:
12734 Cimarron Path
San Antonio, TX 78249-3424
Phone:
N/A
URL:
N/A
EIN:
120229436
DUNS:
192756984
Number of Employees:
5
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $199,956.00 2

Award List:

Encapsulated Vaccines Against Select Agents

Award Year / Program / Phase:
2008 / STTR / Phase I
Award Amount:
$99,957.00
Agency:
HHS
Principal Investigator:
Research Institution:
N/A
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The ultimate goal of the research proposed is the development of vaccines against intracellular pathogens. The model system to be employed is the Brucella spp, a causative agent of infectious abortion in animals (Bang' s disease) and undulant fever, a chronic… More

Nanoparticle Technology for Minimally-invasive Delivery of DNA Vaccines

Award Year / Program / Phase:
2011 / STTR / Phase I
Award Amount:
$99,999.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Allison C. Rice-Ficht, Regents Professor and CMDD Director – (979) 458-1024
Research Institution:
Texas A&M Research Foundation
RI Contact:
Ruth Manning
Abstract:
Venezuelan equine encephalitis virus causes an acute debilitating disease in humans characterized by fever, mylagia, headache, lymphopenia and malaise and can also lead to neurological symptoms and encephalitis. The highly pathogenic strains are frequently associated with epidemics in North Central… More